U.S. Capital Wealth Advisors’s Microbot Medical MBOT Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,000	Closed	-$20K	–	1053
2025 Q4	$20K	Sell	10,000 -1,300	-12%	-$3.08K	﹤0.01%	977
2025 Q3	$34.5K	Buy	11,300 +1,300	+13%	+$4.05K	﹤0.01%	935
2025 Q2	$25.2K	Buy	+10,000	New	+$23.9K	﹤0.01%	885

Other funds holding MBOT

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CBU

CIBC Bancorp USA Chicago, Illinois $74.4B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

U.S. Capital Wealth Advisors's MBOT Position: Q1 2026 in Review

U.S. Capital Wealth Advisors sold out of Microbot Medical (MBOT) in Q1 2026, closing a stake of 10,000 shares — an estimated $20K sold.

U.S. Capital Wealth Advisors first reported a position in MBOT in Q2 2025 and held it in 3 quarters. The position peaked at $34.5K in Q3 2025. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

U.S. Capital Wealth Advisors reported no remaining Microbot Medical position as of Q1 2026 after selling out during the quarter.
U.S. Capital Wealth Advisors sold 10,000 Microbot Medical shares in Q1 2026, an estimated $20K.
U.S. Capital Wealth Advisors first reported a position in Microbot Medical in Q2 2025 and held it in 3 quarters.
U.S. Capital Wealth Advisors's Microbot Medical position peaked at $34.5K in Q3 2025.
79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.